Guangdong Shuanglin Bio-Pharmacy Co | govt.chinadaily.com.cn

Enterprises

Guangdong Shuanglin Bio-Pharmacy Co

Updated: Apr 16, 2019 govt.chinadaily.com.cn Print

广东双林zjst.net.jpg

Guangdong Shuanglin Bio-Pharmacy Co [Photo/zjst.net]

Established in 1995, Guangdong Shuanglin Bio-Pharmacy Co is s a national high-tech enterprise integrating scientific research, development, production and sales of blood products.

The company now produces six varieties of blood products with a total of 16 specifications. It has six national invention patents, six provincial high-tech products, and 16 drug approval documents issued by the State Food and Drug Administration. The company is one of the domestic enterprises in the sector achieving high comprehensive utilization of plasma and offering complete varieties. It is also the enterprise with the largest production of rabies immunoglobulin in the country.

The company has undertaken 16 national, provincial and municipal scientific research projects, seven new technologies, and four new products. It has obtained 16 provincial, municipal and district science and technology awards. It has eight research projects and two pre-research projects. 

The net assets of the company exceed 700 million yuan ($104.19 million), with 13 wholly owned subsidiaries. Its comprehensive strength ranks it in the top 10 biopharmaceutical enterprises in Guangdong province.

Add: 1 East Xinfeng Rd, Mazhang district, Zhanjiang, Guangdong province

Tel: 860-759-3231999

Email: zjslbio@163.com

Website: www.zjslbio.com 

Editors' Picks

LEAVE YOUR MESSAGE

*Your E-mail Address

Copyright©2020 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安备 11010502032503号